ADQUEY

FDA Drug Profile — Difamilast

Drug Details

Generic Name
ADQUEY
Brand Names
Difamilast
Application Number
NDA219474
Sponsor
Acrotech Biopharma Inc
NDC Codes
1
Dosage Forms
OINTMENT
Routes
TOPICAL
Active Ingredients
DIFAMILAST

Indications and Usage

1 INDICATIONS & USAGE ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. ADQUEY is a phosphodiesterase 4 inhibitor indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. (1)